AMERICAS

摘要

The reinforcing market cycle of falling commodities, the rising dollar and weak stocks is keeping a lid on US ECM activity. The fourth-quarter earnings season has also capped issuance in recent weeks, though it is now winding to a close with nearly two-thirds of S&P 500 companies having now reported. On a brighter note, biotechs editas medicine and beicene priced the first two US IPOs of 2016, while two mid-sized sponsor-backed IPOs, solid waste collection company advanced disposal services and airport concessionaire otc exp, are on the pricing slate this week.